Objective
Cancers are complex, continuously evolving diseases unique to each individual patient. Yet, most drugs are administered according to fixed, “one-size-fits-all” strategies that always aim to deliver the maximum tolerated dose until it fails due to toxicity or resistance. “Adaptive Cancer Therapy” (AT) is a novel approach which seeks to delay drug resistance by personalising when and how much drug is given, based on the tumour’s response dynamics. After initial success in prostate cancer, there are now important questions about which patients would benefit from AT, and how should we optimally adapt therapy? In this 2-year fellowship, I will develop a computational framework to: i) understand and track resistance evolution from a patient’s tumour burden data (volume, blood biomarkers, ctDNA), and ii) translate this knowledge into personalised dosing strategies to slow resistance evolution and improve quality-of-life. To predict whether a patient will benefit from AT we need a firm, quantitative understanding of the dynamics of resistance evolution. Under supervision of Prof Trevor Graham at the ICR, I will develop a software package (B-REDi) which integrates a family of mathematical models and Bayesian inference to learn about the evolutionary route to resistance in a patient. Subsequently, I will deploy this package to investigate how AT is altering resistance evolution in a clinical trial in ovarian cancer (ACTOv). Finally, I will use deep reinforcement learning to explore how our calibrated models can guide treatment decisions even under uncertainty about resistance mechanisms. In the future, I plan to establish my own lab to develop computational tools to mitigate resistance and toxicity through schedule personalisation. This project will serve me as a steppingstone towards this goal, and it will contribute novel tools and insights towards a future in which mathematical models are used akin to weather forecasts to inform clinical decision-making.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciencescomputer and information sciencessoftware
- medical and health sciencesclinical medicineoncology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European FellowshipsCoordinator
SW7 3RP London
United Kingdom